First National Bank of Omaha Cuts Position in Avanos Medical, Inc. (NYSE:AVNS)

First National Bank of Omaha lessened its holdings in Avanos Medical, Inc. (NYSE:AVNSGet Rating) by 26.3% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 26,495 shares of the company’s stock after selling 9,454 shares during the quarter. First National Bank of Omaha owned about 0.06% of Avanos Medical worth $888,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Royal Bank of Canada grew its holdings in shares of Avanos Medical by 0.6% during the first quarter. Royal Bank of Canada now owns 522,641 shares of the company’s stock valued at $17,507,000 after buying an additional 3,044 shares during the last quarter. Dynamic Technology Lab Private Ltd grew its holdings in shares of Avanos Medical by 81.8% during the first quarter. Dynamic Technology Lab Private Ltd now owns 27,090 shares of the company’s stock valued at $908,000 after buying an additional 12,189 shares during the last quarter. Goldman Sachs Group Inc. grew its holdings in shares of Avanos Medical by 24.5% during the first quarter. Goldman Sachs Group Inc. now owns 1,998,871 shares of the company’s stock valued at $66,962,000 after buying an additional 392,870 shares during the last quarter. Captrust Financial Advisors grew its holdings in shares of Avanos Medical by 23.9% during the first quarter. Captrust Financial Advisors now owns 2,704 shares of the company’s stock valued at $91,000 after buying an additional 521 shares during the last quarter. Finally, State Street Corp grew its holdings in shares of Avanos Medical by 0.5% during the first quarter. State Street Corp now owns 2,018,705 shares of the company’s stock valued at $67,627,000 after buying an additional 9,410 shares during the last quarter. Hedge funds and other institutional investors own 91.77% of the company’s stock.

Avanos Medical Stock Down 3.0 %

Shares of Avanos Medical stock opened at $23.45 on Friday. The company has a quick ratio of 1.77, a current ratio of 2.89 and a debt-to-equity ratio of 0.20. Avanos Medical, Inc. has a twelve month low of $23.29 and a twelve month high of $36.44. The company has a market cap of $1.11 billion, a price-to-earnings ratio of -146.55 and a beta of 0.87. The company’s 50 day moving average is $26.81 and its 200 day moving average is $28.74.

Avanos Medical (NYSE:AVNSGet Rating) last released its quarterly earnings results on Tuesday, August 9th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.02. Avanos Medical had a negative net margin of 1.02% and a positive return on equity of 5.27%. The business had revenue of $203.00 million for the quarter, compared to the consensus estimate of $208.28 million. During the same period last year, the firm earned $0.21 earnings per share. The company’s quarterly revenue was up 8.9% on a year-over-year basis. Research analysts anticipate that Avanos Medical, Inc. will post 1.53 EPS for the current year.

Analyst Ratings Changes

A number of research firms have recently commented on AVNS. Stifel Nicolaus cut their price target on shares of Avanos Medical from $37.00 to $28.00 in a report on Monday, July 18th. Morgan Stanley lowered their price objective on shares of Avanos Medical from $33.00 to $28.00 and set an “underweight” rating on the stock in a research report on Friday, July 15th. StockNews.com upgraded shares of Avanos Medical from a “hold” rating to a “buy” rating in a research report on Thursday, August 11th. Finally, KeyCorp lowered their price objective on shares of Avanos Medical from $41.00 to $38.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 10th.

Avanos Medical Profile

(Get Rating)

Avanos Medical, Inc operates as a medical technology company. It focuses on delivering clinically medical device solutions to improve patients’ quality of life. The firm’s portfolio of product offerings focuses on respiratory and digestive health, along with surgical and interventional pain management to improve patient outcomes and reduce the cost of care.

Further Reading

Institutional Ownership by Quarter for Avanos Medical (NYSE:AVNS)

Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.